Oncogene Science Incorporated

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Contact Details: 106 Charles Lindbergh Boulevard Uniondale NY 11553-3649 United States of America Tel: 516 222 0023 Fax: 516 222 0114 Email: WWW: www.oncogene.com/

Loading...

Recent Publications by Oncogene Science Incorporated:
HER-2/neu diagnostics in breast cancer. HER-2/neu status of the primary breast cancer (PBC) is determined by...	15th September, 2007	Oncogene Science, Siemens Medical Solutions Diagnostics, Rogers Street,	Breast Cancer Res. 2007;9(3):207. DOI Direct Link
Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers. Pharmaceutical companies have developed targeted therapies such as...	11th May, 2007	Oncogene Science, Siemens Medical Solutions Diagnostics, Cambridge, MA	Expert Rev Mol Diagn. 2007 May;7(3):309-19. DOI Direct Link
Inhibition of the HIV Rev transactivator : a new target for therapeutic intervention. The viral transactivator Rev is essential for HIV replication, since it...	25th March, 2006	Oncogene Science, Inc., 106 Charles Lindbergh Blvd., Uniondale, NY 11553,	Front Biosci. 1997 Jun 1;2:d283-97.
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer. The HER2/neu oncoprotein is a major target for the development of new...	6th October, 2004	Oncogene Science, Bayer HealthCare, Cambridge, MA 02142, USA.	Clin Breast Cancer. 2004 Jun;5(2):105-16.
Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer. BACKGROUND: The HER-2/neu oncogene and its p185 receptor protein are...	8th November, 2003	Oncogene Science, Bayer HealthCare, Cambridge, MA 02142, USA.	Clin Chem. 2003 Oct;49(10):1579-98.
→View more Oncogene Science Incorporated research publications.

BioNews Results for Oncogene Science Incorporated:
Therapeutic Target ID'd for Deadly Childhood Muscle Cancer	Newswise:  Aug 16 2008 12:59AM Matching: oncogene science
Therapeutic Target ID'd for Deadly Childhood Muscle Cancer	Interest!ALERT:  Aug 14 2008 7:07PM Matching: oncogene science

Oncogene Science Incorporated Patents:
US Patent No.	Title
5976793	Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators
5217896	Monoclonal antibodies recognizing parathyroid hormone-like protein
5262319	Method for obtaining bone marrow free of tumor cells using transforming growth factor .beta.3
5262523	Antibodies reactive with normal and oncogenic forms of the ras p21 protein
5401638	Detection and quantification of neu related proteins in the biological fluids of humans
→View more Oncogene Science Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 403 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: oncogene sciences | f | Oncogene Science Bayer Diagnostics | Oncogene Science | oncogene science | oncogene science | oncogene science | oncogene science cambridge ma antibody p21 | oncogene science bayer healthcare | Oncogene Science, Inc uniondale ny | .

Search for more companies in Uniondale

Search for more companies in NY

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Oncogene Science Incorporated

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.